Kazuko Matsuda - 09 Jan 2024 Form 4 Insider Report for MEDICINOVA INC (MNOV)

Role
Chief Medical Officer, Director
Signature
/s/ Yuichi Iwaki, attorney-in-fact
Issuer symbol
MNOV
Transactions as of
09 Jan 2024
Transactions value $
$0
Form type
4
Date filed
11 Jan 2024, 16:52
Previous filing
25 Jan 2023
Next filing
10 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MNOV Employee Stock Option (Right to Buy) Award $0 +158K $0.00 158K 09 Jan 2024 Common Stock 158K $2.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 1, 2023, the reporting person was granted an option to purchase 225,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2023. Such performance criteria for 2023 were achieved at the 70% attainment level, resulting in vesting of the option as to 157,500 shares.